Topics
Medulloblastoma | Treatment | Radiotherapy | Immunomodulatory radiotherapy
Home > Publications > Topics > Medulloblastoma > Treatment > Radiotherapy > Immunomodulatory radiotherapy
2026
Chatterjee S, Kumar P, Kumar AS, Lei PJ, Datta M, Zhao Y, Ho WW,
Talele NP, Andersson P, Duquette M, Kitahara S, Blanc L, Wong SJ,
Kwanten WJ, Ebb DH, Yock TI, Dartois V, Fukumura D, Duda DG, Xu L,
Kim HJ, Jain RK.
Targeting
Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity
and Improves Survival of Mice with Group 3 Medulloblastoma.
bioRxiv
[Preprint]. 2026 Aug 13:2026.08.12.744521. doi:
10.64898/2026.08.12.744521. PMID:
42845663. ˍ